Find High-Quality Human Biospecimens
Find fresh, FFPE (embedded) and flash-frozen tissues from donors with a range of diseases or from healthy tissue.
Peripheral Blood Products
Choose from our inventory of whole blood, serum, and plasma or request a prospective collection.
Order PBMCs, BMMCs, and dissociated tumor cells (DTCs) from healthy and disease-state donors.
Access a full range of biofluids, including urine, synovial fluid, CSF, BAL, saliva and more.
Advance Insight Across Multiple Indications
The high quality human biospecimens offered by Audubon Bioscience support a wide range of disease indications, including:
- Benign Tumors
If we don't deliver on this promise to your satisfaction our replacement service will be free of charge
- High Quality
Your sample and data integrity are of utmost importance to us. High quality procurement, temperature control and sample delivery are ensured to meet your project's standards.
- Strict Compliance
We guarantee that ethical, biomedical and environmental regulations are in place and assured while handling all biospecimens and their associated data.
- Maximum Flexibility
We recognize that every project has specific details and no two projects are alike. We ensure to meet your requirements by being flexible to fit your project’s specifications.
- Donor Respect
We vow to never forget that all biospecimen donations and their associated data originate from a patient. It is our duty to make sure these samples are treated with respect.
- Kept Timelines
We understand that your projects are time-sensitive so we promise to execute your project collection within the strictly agreed timelines.
Global Network of Clinic Locations
Updates from our Blog
March 31, 2021
Today, the continuously growing private sector provides the needed Human Biological Specimens (HBS) to all public and private research groups. However, HBS collection remains a complicated procedure. In this article, we take a look at the key points to consider when choosing the right HBS Provider to secure your research project's success.
From immuno-oncology to targeted therapies and biomarkers identification, novel therapeutic multiplicity is impressive. Despite their diversification, these therapies have few crucial commonalities: they are targeted, personalized, and their development relies strictly on human biospecimen availability.